A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza. - Favor - T705aUS316
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects With Uncomplicated Influenza (T705US316)
The purpose of this study is to determine if favipiravir is effective in reducing the time to resolution of influenza symptoms.
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects With Uncomplicated Influenza
The purpose of this study is to determine if favipiravir is effective in reducing the time to resolution of influenza symptoms.
100 Clinical Results associated with MDVI, LLC
0 Patents (Medical) associated with MDVI, LLC
100 Deals associated with MDVI, LLC
100 Translational Medicine associated with MDVI, LLC